Evolent Health, Inc. — Director's Dealing 2022

Jun 14, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Evolent Health, Inc. (EVH)
CIK: 0001628908
Period of Report: 2022-06-09

Reporting Person: Barbarosh Craig A. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-09	Class A Common Stock	A	5564	—	Acquired	17198	Direct

Footnotes

F1: Represents restricted stock units granted to Mr. Barbarosh pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2: Securities vest on the earlier of June 9, 2023 and the date of the company's 2023 annual meeting, subject to the reporting person's continued service on the vesting date.